Signaling Pathways - Androgen Receptor - 5-HT receptors - Insulin-like growth factors (IGFs) - NADPH Oxidases - c-Kit
清除全部
-
B4763 GKT1378311 CitationTarget: NADPH OxidasesSummary: Nox1/Nox4双重抑制剂 -
B5954 Dasatinib Monohydrate中文名: 达沙替尼一水合物Target: PDGFR|c-Kit|Bcr-Abl|SrcSummary: ABL\SRC\KIT\PDGFR以及其它酪氨酸激酶抑制剂 -
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI) -
B5854 Pexidartinib (PLX3397)3 Citation中文名: 培西达替尼Target: FLT3|c-Kit|CSF1RSummary: CSF-1R抑制剂 -
B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂 -
B6326 Diphenyleneiodonium chloride中文名: 二苯基氯化碘盐Target: NADPH Oxidases|NOS|GPR3Summary: iNOS和eNOS抑制剂，GPR3激动剂 -
B3675 Apocynin中文名: 罗布麻宁，夹竹桃麻素，香兰基甲基酮Target: NADPH OxidasesSummary: 选择性NADPH氧化酶抑制剂 -
B2249 Lamotrigine1 Citation中文名: 拉莫三嗪Target: 5-HT receptors|sodium channelSummary: 5-HT抑制剂，钠通道阻断剂 -
B2171 Imatinib (STI571)中文名: 伊马替尼Target: PDGFR|c-Kit|Bcr-AblSummary: 蛋白酪氨酸激酶抑制剂 -
A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R抑制剂